Our first paper looks at nirsevimab's effectiveness against RSV-related intensive care unit admissions among babies 👶
Tl;dr: it works! ~80% effectiveness for both of these outcomes
www.cdc.gov/mmwr/volumes...
For our fellow nerds,🧵👇
Our first paper looks at nirsevimab's effectiveness against RSV-related intensive care unit admissions among babies 👶
Tl;dr: it works! ~80% effectiveness for both of these outcomes
www.cdc.gov/mmwr/volumes...
For our fellow nerds,🧵👇
This means more babies can get get HepB vaccines and nirsevimab
Now, almost half of babies born in the US should be covered
Progress!! 💪
www.cdc.gov/mmwr/volumes...
This means more babies can get get HepB vaccines and nirsevimab
Now, almost half of babies born in the US should be covered
Progress!! 💪
www.cdc.gov/mmwr/volumes...